4//SEC Filing
FREEMAN KEVIN D 4
Accession 0001133416-24-000036
CIK 0001133416other
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 4:42 PM ET
Size
6.0 KB
Accession
0001133416-24-000036
Insider Transaction Report
Form 4
FREEMAN KEVIN D
Director
Transactions
- Will/Inheritance
Common Stock
2024-04-09+2,063→ 18,063 total(indirect: By IRA)
Holdings
- 75,000(indirect: By LLC)
Common Stock
- 23,469
Common Stock
Footnotes (1)
- [F1]Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeother
Related Parties
1- filerCIK 0001522478
Filing Metadata
- Form type
- 4
- Filed
- Apr 8, 8:00 PM ET
- Accepted
- Apr 9, 4:42 PM ET
- Size
- 6.0 KB